Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clonidine - Therakind

Next Previous
Drug Profile

Clonidine - Therakind

Alternative Names: Clonidine hydrochloride

Latest Information Update: 31 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Therakind
  • Class Analgesics; Anti-inflammatories; Antiglaucomas; Antimigraines; Behavioural disorder therapies; Centrally-acting antihypertensives; Chlorobenzenes; Imidazolines; Small molecules
  • Mechanism of Action Alpha 2 adrenergic receptor agonists; Imidazoline receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Sedation

Most Recent Events

  • 30 Mar 2021 Discontinued - Phase-III for Sedation (In adolescents, In children, In infants, In neonates) in Czech Republic, Estonia, Germany, Italy, Spain, Netherlands, Sweden (IV)
  • 22 Oct 2018 Therakind terminates its phase-III CloSed1 trial in Sedation (In children, In infants, In adolescents, In neonates) in Czech Republic, Estonia, Germany, Italy, Netherlands, Spain, Sweden (IV) due to lack of recruitment (NCT02509273

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top